Julie A. Johnson
Julie Ann Johnson (born 1962) is an American clinical pharmacist and translational scientist. She currently serves as associate dean for clinical and translational research and holds the Dr. Samuel T. and Lois Felts Mercer Professorship of Medicine and Pharmacology at Ohio State University College of Medicine. She is also associate vice president for research at Ohio State.At the University of Florida College of Pharmacy, Johnson was dean emeritus of pharmacy and a distinguished professor in the Department of Pharmacotherapy & Translational Research. Provided by Wikipedia
Showing 1 - 20 results of 26 for search 'Julie A. Johnson', query time: 0.08s
Refine Results
-
1
Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hype... by Lakshmi Manasa S. Chekka, Taimour Langaee, Julie A. Johnson, Julie A. Johnson
Published 2022-03-01
Article -
2
-
3
-
4
-
5
-
6
2235 by Meghan J. Arwood, Caitrin Rowe McDonough, Larisa H. Cavallari, Amanda R. Elsey, Reginald F. Frye, Yan Gong, Julie A. Johnson, Kristin W. Weitzel, Taimour Langaee
Published 2017-09-01
Article -
7
-
8
Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients by Mai Mehanna, Caitrin W. McDonough, Steven M. Smith, Yan Gong, John G. Gums, Arlene B. Chapman, Julie A. Johnson, Lauren McIntyre, Rhonda M. Cooper-DeHoff
Published 2021-09-01
Article -
9
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individuals. by MyPhuong T Le, Maximilian T Lobmeyer, Marcus Campbell, Jing Cheng, Zhiying Wang, Stephen T Turner, Arlene B Chapman, Eric Boerwinkle, John G Gums, Yan Gong, Richard J Johnson, Julie A Johnson
Published 2013-01-01
Article -
10
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers. by Patrick N Cunningham, Zhiying Wang, Megan L Grove, Rhonda M Cooper-DeHoff, Amber L Beitelshees, Yan Gong, John G Gums, Julie A Johnson, Stephen T Turner, Eric Boerwinkle, Arlene B Chapman
Published 2019-01-01
Article -
11
Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta‐Blockers in European Americans by Sonal Singh, Nihal El Rouby, Caitrin W. McDonough, Yan Gong, Kent R. Bailey, Eric Boerwinkle, Arlene B. Chapman, John G. Gums, Stephen T. Turner, Rhonda M. Cooper‐DeHoff, Julie A. Johnson
Published 2019-09-01
Article -
12
Pharmacometabolomics reveals racial differences in response to atenolol treatment. by William R Wikoff, Reginald F Frye, Hongjie Zhu, Yan Gong, Stephen Boyle, Erik Churchill, Rhonda M Cooper-Dehoff, Amber L Beitelshees, Arlene B Chapman, Oliver Fiehn, Julie A Johnson, Rima Kaddurah-Daouk, Pharmacometabolomics Research Network
Published 2013-01-01
Article -
13
Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner. by Amber L Beitelshees, Julie A Johnson, Megan L Hames, Yan Gong, Rhonda M Cooper-Dehoff, Jun Wu, Sharon Cresci, Cynthia X Ma, Carl J Pepine, Michael A Province, John A Spertus, Howard L McLeod
Published 2010-12-01
Article -
14
β1‐receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgery by Leanne Dumeny, Marut Chantra, Taimour Langaee, Benjamin Q. Duong, Daniel H. Zambrano, Frank Han, Dalia Lopez‐Colon, James F. Humma, Jonathan Dacosta, Tommie Lovato, Connie Mei, Julio D. Duarte, Julie A. Johnson, Giles J. Peek, Jeffrey P. Jacobs, Mark S. Bleiweis, Larisa H. Cavallari
Published 2022-03-01
Article -
15
Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network by Nina R. Sperber, Olivia M. Dong, Megan C. Roberts, Paul Dexter, Amanda R. Elsey, Geoffrey S. Ginsburg, Carol R. Horowitz, Julie A. Johnson, Kenneth D. Levy, Henry Ong, Josh F. Peterson, Toni I. Pollin, Tejinder Rakhra-Burris, Michelle A. Ramos, Todd Skaar, Lori A. Orlando
Published 2021-07-01
Article -
16
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics by Mohamed H. Shahin, Yan Gong, Reginald F. Frye, Daniel M. Rotroff, Amber L. Beitelshees, Rebecca A. Baillie, Arlene B. Chapman, John G. Gums, Stephen T. Turner, Eric Boerwinkle, Alison Motsinger‐Reif, Oliver Fiehn, Rhonda M. Cooper‐DeHoff, Xianlin Han, Rima Kaddurah‐Daouk, Julie A. Johnson
Published 2018-01-01
Article -
17
Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies by Ana Caroline C. Sá, Amy Webb, Yan Gong, Caitrin W. McDonough, Mohamed H. Shahin, Somnath Datta, Taimour Y. Langaee, Stephen T. Turner, Amber L. Beitelshees, Arlene B. Chapman, Eric Boerwinkle, John G. Gums, Steven E. Scherer, Rhonda M. Cooper-DeHoff, Wolfgang Sadee, Julie A. Johnson
Published 2018-06-01
Article -
18
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic by Meghan J. Arwood, Eric A. Dietrich, Benjamin Q. Duong, D. Max Smith, Kelsey Cook, Amanda Elchynski, Eric I. Rosenberg, Katherine N. Huber, Ying L. Nagoshi, Ashleigh Wright, Jeffrey T. Budd, Neal P. Holland, Edlira Maska, Danielle Panna, Amanda R. Elsey, Larisa H. Cavallari, Kristin Wiisanen, Julie A. Johnson, John G. Gums
Published 2020-07-01
Article -
19
A randomized, cross‐over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence by Scott A. Mosley, Sarah Kim, Nihal El Rouby, Karthik Lingineni, Valvanera Vozmediano Esteban, Yan Gong, Yiqing Chen, David Estores, Kairui Feng, Hyewon Kim, Minori Kinjo, Taimour Langaee, Zhichuan Li, Siegfried O. F. Schmidt, Julie A. Johnson, Reginald F. Frye, Lanyan (Lucy) Fang, Liang Zhao, Philip F. Binkley, Stephan Schmidt, Larisa H. Cavallari
Published 2022-07-01
Article -
20
Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study by Nicole D. Armstrong, Vinodh Srinivasasainagendra, Lakshmi Manasa S. Chekka, Nam H. K. Nguyen, Noor A. Nahid, Alana C. Jones, Rikki M. Tanner, Bertha A. Hidalgo, Nita A. Limdi, Steven A. Claas, Yan Gong, Caitrin W. McDonough, Rhonda M. Cooper-DeHoff, Julie A. Johnson, Hemant K. Tiwari, Donna K. Arnett, Marguerite R. Irvin
Published 2022-07-01
Article